Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholding for the Period Ended March 21, 2022

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 21, 2022. For more details, kindly Click here
30-03-2022
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Submission Of Certificate From Statutory Auditor In Terms Of Regulation 169(5) Of The Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations, 2018 ('ICDR Regulations')

Pursuant to Regulation 169(5) of the ICDR Regulations, please find enclosed herewith, a certificate issued by S RB C & Co LLP, Chartered Accountants, Statutory Auditors of the Company, certifying that the issuer (i.e. Company) is in compliance with Regulation 169(4) of ICDR Regulations and the relevant documents thereof are maintained by the issuer as on the date of the certificate.
28-03-2022
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilip Shantilal Shanghvi & PACs
23-03-2022
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Allotment

Intimation of Outcome of the meeting of the Securities Allotment Committee held today i.e. on March 21, 2022, in terms of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Details of allotment are provided in the letter attached.
21-03-2022
Next Page
Close

Let's Open Free Demat Account